Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Writing away the pain: Text-Based therapy tested for suicidal youth

NCT ID NCT07479823

Symptom relief Sponsor: Hallym University Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a guided expressive writing program can reduce suicidal thoughts in 160 adolescents and young adults aged 13 to 24. Participants will complete short writing sessions several times a week for four weeks, focusing on emotions and personal experiences. Researchers will compare changes in suicidal thoughts, depression, and impulsivity between those who do the writing program plus usual care and those who receive usual care alone.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Structured expressive writing program
What this could lead to
If it works, this could offer a simple, low-cost tool to help young people manage suicidal thoughts and emotional distress.
What could go wrong
This is an early-stage trial with a behavioral intervention, so results may be modest or not generalize. The writing program is added to usual care, not a replacement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 160 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Mar 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

13 to 24 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adolescents or young adults aged 13 to 24 years. * Individuals with a history of suicidal ideation, suicide attempts, or non-suicidal self-injury. * Individuals currently receiving mental health services or who have been evaluated as having suicide risk within the past 6 months. * Ability to read and write in Korean. * For participants under 19 years of age, both participant assent and parental consent are required. Exclusion Criteria: * Individuals requiring immediate psychiatric hospitalization. * Severe intellectual disability or neurodevelopmental disorder that prevents participation in writing activities. * Acute psychosis or manic episode that would interfere with participation in the study. * Participation in another suicide prevention clinical trial during the study period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adolescent mental health are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Self-Injurious Behavior Suicidal Ideation Suicide Prevention

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adolescent mental health Self-injurious behavior Suicidal ideation Suicide risk

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.